X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying
Tue, 22 Aug 11:30 am

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line. Sectoral indices are trading on a mixed note with stocks in the energy sector and pharma sector witnessing maximum buying interest. Realty stocks and auto sector are trading in the red.

The BSE Sensex is trading up by 75 points (up 0.3%) and the NSE Nifty is trading up by 30 points (up 0.3%). The BSE Mid Cap index is trading up by 0.3%, while the BSE Small Cap index is trading up by 0.6%. The rupee is trading at 64.24 to the US$.

In news from stocks in the pharma sector. Lupin share price is in focus today after the US drug regulator issued an Establishment Inspection Report (EIR).

As per an article in a leading financial daily, Lupin received notification that the inspection carried out by the US Food and Drug Administration (USFDA) in April 2017 at its Aurangabad facility is now closed.

The US regulator issued an EIR which closes all outstanding USFDA inspections at Lupin's Aurangabad facility.

One must note that, the plant contributes around 10-15% to the company's US sales and has several abbreviated new drug applications (ANDAs) pending approval.

Lupin's management has a proven history of dealing with regulatory challenges and making niche launches.

However, Lupin has been facing heat from USFDA for some months now. The US regulator had recently given observations on the company's Goa plant, the most important with respect to exports to the US, in April. In May, the Indore unit of the pharmaceutical manufacturer received six observations from USFDA.

US Remains Key Growth Driver

Lupin derives 43% of its global revenues from the US. The US continues to be a principle growth driver for the company. Lupin enjoys a strong brand equity in the US and is the 5th largest pharmaceuticals company by prescriptions in the country.

However, the pharma sector, once considered a safe haven for investors has been on a steady decline over the past two years.

In such a scenario, what is key to identifying potential multibagger stocks? How does one pick them at the right time and ride them to their full potential? How many multibaggers do you really need to achieve the big riches that you desire?

Just Released: Multibagger Stocks Guide
(2017 Edition)

In this report, we reveal four proven strategies to picking multibagger stocks.

Well over a million copies of this report have already been claimed over the years.

Go ahead, grab your copy today. It's Free.

NO-SPAM PLEDGE - We will NEVER rent, sell, or give away your e-mail address to anyone for any reason. You can unsubscribe from The 5 Minute WrapUp with a few clicks. Please read our Privacy Policy & Terms Of Use.

Most importantly, are there any stocks right now that could turn out to be multibaggers? Click here to know everything that you need to know right now about mutlibagger stocks...

At the time of writing, Lupin share price was trading up by 2%.

Moving on to the news from the economy. Foreign direct investment (FDI) in India zoomed 37% during the first quarter (April-June) of fiscal year 2017-18 to touch US$ 10.4 billion.

According to the figures of the Department of Industrial Policy and Promotion (DIPP), India had received US$ 7.6 billion FDI during April-June 2016-17.

The main sectors which attracted the highest foreign inflows include services, telecom, trading, computer hardware and software and automobile. Bulk of the FDI came in from Singapore, Mauritius, the Netherlands and Japan.

FDI equity inflow in manufacturing sector grew by 31% to US$ 4.2 billion during April-June this fiscal.

In addition, since the launch of 'Make in India' initiative (October 2014 - June this year), foreign inflows jumped 64% to US$ 110.1 billion from US$ 67.3 billion in the same period last year, the reports noted.

The government has announced several steps to attract foreign inflows.

The measures include liberalisation of FDI policy and improvement in business climate.

Foreign investments are considered crucial for India, which needs around US$ 1 trillion for overhauling its infrastructure sector such as ports, airports and highways to boost growth.

A strong inflow of foreign investments will help improve the country's balance of payments situation and strengthen the rupee value.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Please Note: The stock price of Yes Bank on NSE-50 is not adjusted for face value split. Kindly refer to its BSE's quote today for the adjusted price.

Equitymaster requests your view! Post a comment on "Sensex Trades on a Volatile Note; Energy Stocks Witness Buying". Click here!

  

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Sep 22, 2017 (Close)

MARKET STATS